# Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization

Study · id `cardio:ct-nct05670028` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05670028](<https://clinicaltrials.gov/study/NCT05670028>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05670028

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05670028. Randomized; no masking; primary purpose treatment. Start 2023-06-04 (anticipated); primary completion 2026-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05670028, source copy `cardio:ctgov-nct05670028-2023-01-05`, retrieved 2026-10-26)
- Planned start: 2023-06-04 (anticipated) (ClinicalTrials.gov record NCT05670028, source copy `cardio:ctgov-nct05670028-2023-01-05`, retrieved 2026-10-26)
- Primary completion: 2026-01-31 (anticipated) (ClinicalTrials.gov record NCT05670028, source copy `cardio:ctgov-nct05670028-2023-01-05`, retrieved 2026-10-26)
- Completion: 2026-06-04 (anticipated) (ClinicalTrials.gov record NCT05670028, source copy `cardio:ctgov-nct05670028-2023-01-05`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05670028-2023-01-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization
- Acronym: RESCUE-CA
- Condition: Ischemic Stroke
- Condition: Revascularization
- Condition: Blood Pressure
- Condition: Cerebrovascular Insufficiency
- Condition: Cerebral Autoregulation
- Condition: Individuation
- Condition: Hemorrhagic Transformation Due to Acute Stroke
- Intervention (Drug): Hypotensive Drugs and/or Vasoactive Drugs
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: d943623c5f1d480d2f5752fc1448357b1aa31bde19e563ff6068e5bde8957a52
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
